Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

773
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
773
Insomnia01:27

Insomnia

572
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
572
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

526
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
526
Insufficient Sleep and Sleep Deprivation01:13

Insufficient Sleep and Sleep Deprivation

1.3K
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
1.3K
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

1.9K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
1.9K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

805
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
805

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Prodromal Parkinson's Disease-Like Features in Long COVID With Dream-Enactment Behaviours.

Journal of sleep research·2026
Same author

Covid-19 pandemic and fatal sleepiness-related motor vehicle accidents in Finland.

Sleep medicine·2026
Same author

Sleep Duration, Chronotype, and Mortality in Parkinson's Disease: A Prospective Cohort Study.

Nature and science of sleep·2026
Same author

Corrigendum to "Long COVID as a risk factor for hypersomnolence and fatigue: insights from the 2nd International Covid Sleep Study Collaboration (ICOSS-2)" [Sleep Med. 136 (2025) 106764].

Sleep medicine·2026
Same author

Relationship between family environmental factors and infant sleep: Family factors and infant sleep.

Infant mental health journal·2026
Same author

A decade of change in age, sex distribution, and comorbidities of obstructive sleep apnoea in Finland.

European journal of public health·2025

Related Experiment Video

Updated: Mar 24, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
04:34

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

Published on: February 17, 2023

1.7K

[Update on Current Care Guideline: Insomnia].

Markku Partinen, Anne Huutoniemi, Soili Kajaste

    Duodecim; Laaketieteellinen Aikakauskirja
    |March 9, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Differentiating insomnia symptoms from insomnia disorder is crucial for accurate diagnosis and treatment. Cognitive behavioral therapy is the recommended first-line treatment, with limited use of hypnotics.

    More Related Videos

    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
    04:33

    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

    Published on: April 26, 2024

    1.6K
    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
    05:59

    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

    Published on: October 20, 2023

    3.3K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
    04:34

    Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia

    Published on: February 17, 2023

    1.7K
    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
    04:33

    Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

    Published on: April 26, 2024

    1.6K
    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System
    05:59

    Author Spotlight: Overcoming Challenges in Drosophila Sleep Measurement Using DAM System

    Published on: October 20, 2023

    3.3K

    Area of Science:

    • Sleep Medicine
    • Neurology
    • Psychiatry

    Background:

    • Insomnia symptoms require careful differentiation from a formal insomnia disorder diagnosis.
    • Insomnia can be a secondary symptom of various underlying medical conditions.
    • Accurate diagnosis is essential for effective patient management and treatment planning.

    Purpose of the Study:

    • To provide updated guidance on the diagnosis and management of insomnia.
    • To highlight first-line treatment options and contraindications for specific populations.
    • To address new considerations including insomnia in pregnant and menopausal women, cancer patients, and driving safety.

    Main Methods:

    • Review and synthesis of current scientific literature and clinical guidelines.
    • Focus on differentiating insomnia symptoms from insomnia disorder.
    • Evaluation of treatment efficacy and safety profiles for various interventions.

    Main Results:

    • Cognitive behavioral methods are established as the primary treatment for insomnia disorder.
    • Hypnotic medication use for acute insomnia should not exceed two weeks.
    • Long-term hypnotic use in elderly individuals may present more risks than benefits.

    Conclusions:

    • Emphasizes the importance of distinguishing insomnia symptoms from insomnia disorder for appropriate care.
    • Recommends cognitive behavioral therapy as the preferred initial treatment approach.
    • Addresses specific patient groups and safety concerns, including medication use in the elderly and driving implications.